Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 10, 2012Journal of Nuclear MedicineOpen Access

Oncologic PET/MRI, Part 2: Bone Tumors, Soft-Tissue Tumors, Melanoma, and Lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

CBChristian BuchbenderHeinrich Heine University DüsseldorfTHTill A. HeusnerDüsseldorf University HospitalTLThomas C. LauensteinDüsseldorf University Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Buchbender et al. (2012) studied this question.

synapsesocial.com/papers/6a6fdeba26770c2b8de034bbhttps://doi.org/10.2967/jnumed.112.109306
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1<sup>18</sup>F-FDG PET/CT for Early Response Assessment in Diffuse Large B-Cell Lymphoma: Poor Predictive Value of International Harmonization Project Interpretation2011 · 156 citations
  2. 2Prospective Study of Fluorodeoxyglucose–Positron Emission Tomography Imaging of Lymph Node Basins in Melanoma Patients Undergoing Sentinel Node Biopsy1999 · 176 citations
  3. 3FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas2009 · 195 citations
  4. 4Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques2008 · 341 citations
  5. 5Chemotherapy response assessment in stage IV melanoma patients—comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B2008 · 46 citations